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A 52-year-old male was admitted to the Department of General Thoracic Surgery with a right-side localized pyopneumotho-
rax that showed no improvement after conservative treatment. Open-window thoracostomy was created due to the pres-
ence of bronchopleural fistula. The capacity of the cavity was 600 ml. On the 11th postoperative day, a spontaneous closure 
of the bronchopleural fistula occurred. Later, a vacuum-assisted device was used for the residual empyema cavity treatment. 
It was used for 15 days, sponges were changed every 5 days. The residual cavity reduced in size six times (till 100 ml). The pa-
tient was discharged for a daily dressing changing at the outpatient department. After two months the patient was ready for 
a radical closure of open-window thoracostomy. The postoperative period was uneventful. The case shows that the vacuum-
assisted closure therapy can be safely used in open-window thoracostomy after pleural empyema. This method reduces the 
duration of open-window thoracostomy and accelerates surgical closure.
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Penkiasdešimt dvejų metų vyras dėl dešinio riboto piopneumotorakso buvo hospitalizuotas į Krūtinės chirurgijos skyrių, nes 
konservatyvus gydymas buvo neveiksmingas. Dėl persistuojančios bronchopleurinės jungties padaryta pleurostoma. Vienuo-
liktą pooperacinę parą bronchopleurinė jungtis savaime išnyko, todėl buvo nuspręsta naudoti vakuuminę žaizdų gydymo 
sistemą. Aktyvios aspiracijos sistema per sidabru impregnuotą kempinę naudota 15 dienų (kempinės keistos kas penkias 
dienas). Po šio gydymo kurso pleurostomos tūris sumažėjo nuo 600 ml iki 100 ml. Pacientas išrašytas gydytis ambulatoriškai. 
Po dviejų mėnesių ertmė buvo sumažėjusi iki 10 ml, visiškai epitelizavosi ir buvo tinkama torakoplastinei operacijai. Gydant 
pleuros empiemą, kuri komplikavosi piopneumotoraksu, galima sėkmingai naudoti vakuuminę žaizdų gydymo sistemą. Šis 
gydymo metodas sutrumpina liekamosios pleuros ertmės egzistavimą ir leidžia greičiau atkurti krūtinės sienos vientisumą.
Reikšminiai žodžiai: pleuros empiema, piopneumotoraksas, vakuuminė žaizdų gydymo sistema, pleurostoma
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Introduction
Pleural empyema, defined as pus in the pleural space or 
an effusion with organisms seen on Gram stain, is still a 
controversial issue [1]. The mortality rate from pleural 
space infections ranges within 6–24% [2]. Most com-
mon bacterias that are found in empyema cases are the 
ones that are found in pneumonia patients: Streptococ-
cus Milleri and Streptococcus pneumoniae, Staphylococcus 
aureus, Enterobacteriaceae, and anaerobes [1, 3]. Pyo-
pneumothorax is a complication of pleural empyema 
when there is pus and air collection in the pleural space. 
It usually develops when a spontaneous bronchopleural 
fistula (BPF) occurs because of a bronchial pneumonia 
or lung abscess. Radiographic (chest X-ray, computed 
tomography (CT), and ultrasound) imaging helps 
evaluating and managing pleural empyema [4]. 
The basics of treatment are antibiotic therapy and 
pleural space drainage, debridement and removing of 
encapsulated pleural layers [5]. Antibiotics are given 
empirically and adjusted by growing cultures. For pleu-
ral space debridement, video-assisted thoracic surgery 
(VATS) or open thoracotomy should be considered. 
A more aggressive approach depending on the general 
medical condition and presence of the BPF is open-
window thoracostomy (OWT) [1, 6]. 
Since its introduction, vacuum-assisted closure 
(VAC) therapy has been initially used in the manage-
ment of a wide range of complex wounds. The VAC 
benefits include the removal of the accumulating fluid, 
increased oxygen tension in the wound, increased blood 
flow, and increased granulation tissue proliferation [7]. 
For many years, VAC has been used for sternum wound 
infections. Some recent series reported the possibility to 
use VAC for complex chest wounds as well as in combi-
nation with OWT [5, 8, 9]. Even a minimally invasive 
VAC procedure with instillation offers an advantage of 
flushing the pleural space with antiseptic solution and 
the absence of an OWT [7, 10].  
We would like to present the first case in Lithuania 
of a successfully used VAC system in the treatment of 
localized pyopneumothorax via OWT.
Clinical case
A 52-years-old male was presented to the Department 
of General Thoracic Surgery with cough, the right-sided 
chest pain, and weakness. A history of previous pancre-
atitis and arterial hypertension was known. The patient 
had got ill three weeks ago when he started coughing 
and had a febrile fever. The first week patient didn’t 
seek for any medical help; his status worsened, therefore 
Figure 1. Chest X-ray on admition: the air–fluid level in the posterior aspect of the right chest 
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he went to his family doctor. According to the clinical 
signs and chest X-ray, right-sided pneumonia was diag-
nosed, and peroral antibiotic therapy was started. One 
week later, as there was neither clinical nor radiological 
improvement, he was admitted to the Department of 
Internal Medicine where intravenous antibiotic therapy 
was initiated. Unfortunately, this treatment also showed 
no clinical or radiological improvement. The patient’s 
status even worsened, severe dyspnea occurred, and for 
the next three days he was transferred to the Intensive 
Care Unit where Imipenem and Cilastatin were given to 
him. On the chest X-ray, the right pleural thickening and 
the air-fluid level were observed (Figure 1). Therefore, 
the patient was presented to a thoracic surgeon. On the 
ultrasound evaluation, nonhomogeneous collections of 
fluid with air bubbles were found in the right pleural cav-
ity. The CT scan revealed an encapsulated pyopneumo-
thorax (Figure 2). Blood tests showed signs of infection: 
leukocytosis (15400/µl), elevated C-reactive protein 
levels (142.1 mg/l), and anemia (hemoglobin 97.6 g/l). 
Right-sided pyopneumothorax was diagnosed, and 
the patient was moved to the Department of General 
Thoracic Surgery. Bronchoscopy showed the narrowing 
of the right lower lobe bronchi because of the pressure 
from outside; however, no endobronchial lesions were 
found. Because of the evidence of BPF, the posterior 
localization of the pyopneumothorax cavity and severe 
general status of the patient, right mini-thoracotomy 
with the resection of the eighth right rib was chosen as a 
method of surgical management. The thickened parietal 
pleura (one centimeter), 600 ml of pus and debris were 
found in the pleural cavity. The cavity was cleaned. The 
lung around the cavity was firmly attached to the chest 
wall, the surface was covered with a fibrin debris cortex, 
and the BPF was identified. The decision was made to 
perform an OWT. In addition, part of the ninth rib was 
resected, and an OWT was accomplished. The bacterial 
culture from the pleura showed Staphylococcus aureus 
growth, therefore Cefazoline intravenously was given. 
The histological examination of the pleura showed a 
nonspecific purulent pleuritis. After the operation, the 
OWT dressings were changed daily with betadine and 
hypertonic solutions. The postoperative period had no 
complications and showed a clinical and radiological 
improvement. The bronchopleural fistula closed spon-
taneously on the 11th postoperative day. 
Figure 2. CT scan on admission: encapsulated collection of 
material with air bubles in the right pleural cavity
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The opened empyema cavity remained 600 ml in size 
(Figure 3). We decided to apply the VAC system willing 
to reduce the cavity and to accelerate the cure (Figure 4). 
The VAC treatment was provided for the next 15 days. 
Silver sponges were changed every five days only under 
sedation. The VAC resulted in a quick reducing of the 
wound and the general clinical improvement. The VAC 
was removed when the pleural cavity was free from 
debris, granulations of the cavity surface were seen, and 
there was a negative culture from the cavity. After the 
treatment, the OWT volume reduced from 600 ml to 
100 ml. The patient was discharged to the outpatient 
department with a healing OWT (Figure 5). After 
2 months the patient’s OWT remained only 10 ml in 
size and was ready to be closed (Figure 6). However, the 
patient had a stroke, and the surgical closure had to be 
postponed. After 8 months, only a tiny chest wall defect 
was observed. The patient was offered to close the OWT, 
and a thoracoplastic surgery was performed. The patient 
was discharged on the 8th postoperative day. Figure 7 
shows a view 50 days after thoracoplasty.
Figure 3. OWT before VAC placement
Figure 4. VAC installation
Figure 5. OWT on discharge (after VAC removal)
Figure 6. OWT after a 2-month follow-up
Figure 7. 50 days after the OWT closure
50 G .  V a i t ė n a s ,  Ž .  J a g e l a v i č i u s ,  V .  J o v a i š a s ,  R .  J a n i l i o n i s
Discussion
Open-window thoracostomy is sometimes used in treat-
ing pleural empyema depending on the general patient’s 
status or when bronchopleural fistulas are present. A 
fistula has a high risk of reinfection of the cavity if the 
chest is closed [1]. Although OWT requires quite a long 
treatment, it is safe, effectively controls the infection, 
and sometimes is lifesaving. The VAC therapy initially 
was introduced in order to reduce the time of treatment 
and to accelerate the healing process. After satisfactory 
results in treating superficial infected wounds and post- 
-sternotomy infections, VAC was suggested for pleural 
infections. The main advantages of VAC are obliteration 
of the dead space among tissue layers and the stimula-
tion of angiogenesis caused by a negative pressure [11, 
12], thus resulting in a faster healing and a lower risk of 
reinfection. The first report of intrapleural VAC therapy 
was published in 2006, and there is a constantly grow-
ing number of reports showing VAC advantages in the 
treatment of pleural empyema [7, 9, 13–15]. In this 
case, VAC was considered only after the bronchopleural 
fistula had closed because the persisting fistula creates an 
air leak and dehermetizes the space. On the contrary, 
some authors think that VAC treatment may be used 
even when bronchopleural fistulas are present [16]. An 
earlier VAC installment may result in a shorter hospi-
talization time. We used VAC for 15 days, which is a 
relatively short period of time resulting in an incomplete 
healing of the OWT. A decision for secondary closure of 
the OWT was made two months after seeing the patient 
in the outpatient department. The reasons were a stable 
healing and a significant contraction of the OWT. The 
OWT cavity remained only 10 ml in size and was fully 
epithelized, so it was ready to be closed. In our experi-
ence, the possibility to close the defects after OWT 
without a VAC system usually is 6 to 12 months after 
its formation. 
Conclusions
The case shows that the VAC system could significantly 
fasten the healing process and diminish the OWT cav-
ity. Pyopneumothorax can be safely and faster cured by 
OWT with a VAC system. This method reduces the 
OWT period and accelerates surgical closure.
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